In the April-September 2021 period, the FDI inflows continued to be buoyant at Rs 4,413 crore, growing at the rate of 53 per cent over the same period in 2020-21
The combination rapid antigen test quickly differentiates between SARS-CoV-2 and influenza viruses A and B infections, with results ready in less than 30 minutes, allowing informed decisions on patient and pandemic management decisions
The company is marketing the kit under the brand name CoviFind and it can detect the infection in 15 minutes
The notification implies that any export of Rapid Antigen Kit will require a licence or permission from DGFT
Much-needed diagnostics supplies will help accelerate testing capabilities of hospitals and clinics across India
We have the chance to build an IP estate that goes hand in hand with our generic pharmaceutical strength and build proprietary biological platforms
BPDCN typically presents with skin lesions before rapidly spreading to the bone marrow, lymph nodes
From import dependence to global leadership, the next phase of growth must be driven not only by manufacturing scale and policy support, but also by innovation, research, and globally competitive healthcare technologies
The platform created by NIT Rourkela researchers is capable of delivering rapid, accurate, and repeatable imaging results with minimal human intervention
The company is set to unveil new clinical data across obesity, diabetes, kidney, and liver disease programs
Subscribe To Our Newsletter & Stay Updated
